Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 2750
Single User License Price INR 192500
Corporate User License Price USD 4500
Corporate User License Price INR 315000
Site License Price USD 3500
Site License Price INR 245000
Request a Quote

Report Title

Coronary Stents Market Report: Drivers, Restraints and Opportunities, Trends and Forecasts to 2023

Quote Request for License Type
License Type Price  
Single User License USD 2750
Site License USD 3500
Enterprise Wide License USD 4500
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

Coronary Stents Market Report: Drivers, Restraints and Opportunities, Trends and Forecasts to 2023


Quote Request for License Type
License Type Price  
Single User License USD 2750
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

Coronary Stents Market Report: Drivers, Restraints and Opportunities, Trends and Forecasts to 2023

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

Coronary Stents Market Report: Drivers, Restraints and Opportunities, Trends and Forecasts to 2023



Executive Summary

Indian Market Scenario for Coronary Stent

Cardiovascular diseases account for closely 25% of the deaths in India among the age group of 25 and 70 years. The total number of percutaneous coronary interventions (PCI) is growing gradually at a mid CAGR. In 2016, 495,000 PCI procedures were carried out in India, using 594,000 stents (with an average of 1.2 stents per procedure). Out of these, 80% of the procedures performed used drug-eluting stents (DES), with over 60% of the stents being imported. These MNCs classically go through a supply chain, where the distributors manage the procurement and storage of the stents, and later ship them to the hospitals on requirement. The hospitals add their share of profit to the procured price and bill accordingly. This led to a wide gap between the actual cost of the stent and the selling price to the patient. The average selling price (ASP) of a bare metal stent (BMS) used to be as high as Rs.45,000 (USD 670) and the drug-eluting stents were priced more than Rs.120,000 (USD 1,800). This generated a profit between 270% to 1,000%.

 

Ceiling fixed prices for coronary stents

The notification by National Pharmaceutical Pricing Policy categorizes the stents into bare metal stents (BMS) and drug-eluting stents (DES). Bare metal stents are not to be priced more than Rs.7,260 (USD 110), while drug-eluting stents should be priced below Rs.29,600 (USD 450). This is 40% lesser than the previous prices.

Manufacturer Brand Prices (Rs)

Abbott Laboratories Aborb/ Absorb GT1 31,689

Abbott Laboratories Xience Alpine 31,689

Abbott Laboratories Xience Prime 24,675

Abbott Laboratories Xience Pro 24,675

Abbott Laboratories Xience V 24,675

Abbott Laboratories Xience Xpedition 31,689

Boston Scientific Corporation Promus Element

Boston Scientific Corporation Promus Premier 31,689

Boston Scientific Corporation Synergy 31,689

Meril Life Science Biomime 23,625

Sahajanand Medical Technologies Supraflex 23,289

Biotronik Orsiro 31,689

Vascular Concept Limited Pronova XR 31,689

 

Does this also include imported stents?

The notification makes no discrepancy between branded or unbranded stents, locally manufactured or imported stents. Any stent sold in the Indian market cannot be charged more than Rs.29,600 (USD 450), though there is the addition of local taxes to these prices. The manufacturers with higher selling price than the cap will have to reduce the prices of their stents, while those selling at lesser prices should maintain their original MRP.

Indian Market Scenario

The Indian coronary stent market is worth currently around USD 500 million and is anticipated to grow many times in the future due to the growing number of diabetes and hypertension cases. International stent manufacturers, who hold around 60% of the market, are unhappy with the price capping. Hence, they are planning to with withdraw their advanced products from the Indian market and are planning not to bring in the new-generation products in the future. This change may affect the procedural outcomes, especially in complex cases. Thus, India is expected to face more challenges in the future. Abbott requested the removal of its Alpine and Absorb stents from the Indian market, while Medtronic requested to withdraw its Onyx stents. Following them, Boston petitioned for the removal of synergy stents. But their request was rejected by the Indian authorities. This has given a better opportunity for the domestic manufacturers to increase their market share which currently hold less than 40% share.

Regulatory changes for price control

In July 2016, the coronary stents were included in the National List of Essential Medicines, 2015 (NLEM, 2015) by the Ministry of Health and Family Welfare.

In December 2016, the coronary stents were given the status of scheduled formulation as in the Drug Price Control Order 2013, by the Department of Pharmaceuticals.

 

Coronary Stents-competitive scenario

The coronary stents market is segmented into bare metal stents, drug-eluting stents, and bioabsorbable stents. Approximately 90% of all the percutaneous coronary intervention (PCI) surgeries use a coronary stent. Thus, drug-eluting stents hold the major share in the market. The highest growth rate is expected in the bioresorbable stents due to the advantages of the polylactic acid material. The market is also witnessing various mergers, acquisitions, and collaborations among the top players, which is defining the future of the Global Coronary Stents Market.

The exit of Johnson and Johnson from the coronary stents market has provided an opportunity for many players to strengthen their market share. Abbott Laboratories, Medtronic, and Boston Scientific Corporation are the market leaders in the global coronary stents market in 2016. The top three market players are estimated to hold more than 60% share of the market in 2016. Abbott Laboratories emerged to be the global leader, while Boston Scientific Corporation dominated the market in Brazil and other emerging Latin American countries.

Global coronary stents market growth

The Global Coronary Stents Market is expected to grow at a CAGR of 6.1% during the forecast period 2017-2023. The market is analyzed based on regions and verticals. The market in emerging regions, mergers and acquisitions, and the increase in clinical trials are some factors providing opportunities for the market growth during the forecast period.

Table of Contents

1 Industry Outlook 8

1.1 Industry Overview 8

1.2 Industry Trends 8

1.3 PEST Analysis 9

2 Report Outline 9

2.1 Report Scope 9

2.2 Report Summary 10

2.3 Research Methodology 11

2.4 Report Assumptions 11

3 Market Snapshot 12

3.1 Total Addressable Market 12

3.2 Segmented Addressable Market 12

3.3 Related Markets 13

3.3.1 Interventional Cardiology 13

3.3.2 Peripheral Vascular Stents 13

3.3.3 Atherectomy 14

4 Market Outlook 15

4.1 Market Definition-Infoholic Research 15

4.2 Causes for Coronary Heart Disease 15

4.3 Market Segmentation 15

4.4 Porter 5(Five) Forces 15

5 Market Characteristics 16

5.1 Evolution 16

5.2 Stents Platforms 17

5.3 Market Dynamics 18

5.3.1 Drivers 18

5.3.1.1 Increasing prevalence of cardiovascular diseases 18

5.3.1.2 Increasing aging population 18

5.3.1.3 Growing acceptance for minimally invasive endovascular surgeries 19

5.3.2 Opportunities 19

5.3.2.1 Market expansion opportunities in emerging nations 19

5.3.2.2 Increasing clinical trials 19

5.3.3 Restraints 19

5.3.3.1 Stringent regulations for approval 19

5.3.3.2 High cost of treatment associated with stent implants 20

5.3.3.3 Availability of alternative treatment procedure 20

5.4 DRO-Impact Analysis 20

5.5 Key Stakeholders 21

6 Coronary Stents Pipeline 22

6.1 Overview 22

7 Types: Market Size and Analysis 25

7.1 Overview 25

7.2 Bare Metal Stents (BMS) 25

7.3 Drug Eluting Stents 26

7.4 Bio-absorbable Stents 27

8 End-users: Market Size and Analysis 28

8.1 Overview 29

8.2 Hospitals 29

8.3 Ambulatory Surgical Centers (ASCs) 29

8.4 Cardiac Centers 30

9 Regions: Market Size and Analysis 30

9.1 Overview 30

9.2 North America 31

9.2.1 US 32

9.2.2 Canada 33

9.3 Europe 33

9.3.1 UK 34

9.3.2 Germany 34

9.3.3 France 35

9.4 Asia Pacific 35

9.4.1 Japan 36

9.4.2 China 36

9.4.3 India 36

9.5 Rest of the World 37

9.5.1 Africa 38

9.5.2 Brazil 38

10 Competitive Landscape 38

10.1 Overview 38

11 Vendors Profile 41

11.1 Abbott Laboratories (Abbott) 41

11.1.1 Overview 41

11.1.2 Business Unit 45

11.1.3 Geographic Presence 46

11.1.4 Business Focus 46

11.1.5 SWOT Analysis 47

11.1.6 Business Strategy 47

11.2 Boston Scientific Corp. (Boston) 48

11.2.1 Overview 48

11.2.2 Business Units 51

11.2.3 Geographic Presence 52

11.2.4 Business Focus 52

11.2.5 SWOT Analysis 53

11.2.6 Business Strategies 53

11.3 B. Braun Melsungen AG 54

11.3.1 Overview 54

11.3.2 Business Units 56

11.3.3 Geographic Presence 57

11.3.4 Business Focus 57

11.3.5 SWOT Analysis 58

11.3.6 Business Strategies 58

11.4 Medtronic Plc 59

11.4.1 Overview 59

11.4.2 Business Units 66

11.4.3 Geographic Presence 67

11.4.4 Business Focus 68

11.4.5 SWOT Analysis 69

11.4.6 Business Strategies 69

11.5 MicroPort Scientific Corporation 70

11.5.1 Overview 70

11.5.2 Business Units 73

11.5.3 Geographic Presence 74

11.5.4 Business Focus 75

11.5.5 SWOT Analysis 75

11.5.6 Business Strategies 76

12 Companies to Watch For 76

12.1 Terumo Corp. 77

12.1.1 Overview 77

12.2 Biosensors International Group 79

12.2.1 Overview 79

12.3 BIOTRONIK 80

12.3.1 Overview 80

12.4 Meril Life Science 81

12.4.1 Overview 81

12.5 STENTYS S.A. 82

12.5.1 Overview 82

12.5.2 Overview 82

Annexure 84

Abbreviations 84

 

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

Charts

 

CHART 1 PEST ANALYSIS OF GLOBAL CORONARY STENTS MARKET 10

CHART 2 RESEARCH METHODOLOGY OF GLOBAL CORONARY STENTS MARKET 12

CHART 3 GLOBAL CORONARY STENTS MARKET REVENUE FORECAST, 2016-2023 (USD MILLION) 14

CHART 4 GLOBAL CORONARY STENTS MARKET SEGMENTATION 16

CHART 5 PORTER 5 FORCES ON GLOBAL CORONARY STENTS MARKET 16

CHART 6 MARKET DYNAMICS-DRO ANALYSIS 19

CHART 7 DRO-IMPACT ANALYSIS OF GLOBAL CORONARY STENTS MARKET 21

CHART 8 KEY STAKEHOLDERS 22

CHART 9 GLOBAL CORONARY STENTS MARKET BY TYPE SEGMENTATION, 2023 (%) 26

CHART 10 GLOBAL BARE METAL STENTS (BMS) MARKET REVENUE FORECAST, 2016-2023 (USD MILLION) 27

CHART 11 GLOBAL DRUG ELUTING STENTS MARKET REVENUE, 2016-2023 (USD MILLION) 28

CHART 12 GLOBAL BIO-ABSORBABLE STENTS MARKET REVENUE, 2016-2023 (USD MILLION) 29

CHART 13 GLOBAL CORONARY STENTS MARKET BY END-USER SEGMENTATION, 2016 VS 2023 (%) 30

CHART 14 GLOBAL CORONARY STENTS MARKET BY GEOGRAPHICAL SEGMENTATION, 2016 (%) 31

CHART 15 CORONARY STENTS MARKET REVENUE IN NORTH AMERICA, 2016-2023 (USD MILLION) 32

CHART 16 CORONARY STENTS MARKET REVENUE IN THE EUROPE REGION, 2016-2023 (USD MILLION) 34

CHART 17 CORONARY STENTS MARKET REVENUE IN THE APAC REGION, 2016-2023 (USD MILLION) 36

CHART 18 CORONARY STENTS MARKET REVENUE IN THE REST OF THE WORLD REGION, 2016-2023 (USD MILLION) 38

CHART 19 ABBOTT LABORATORIES.: OVERVIEW SNAPSHOT 44

CHART 20 ABBOTT LABORATORIES.: BUSINESS UNITS 46

CHART 21 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE 47

CHART 22 ABBOTT LABORATORIES.: SWOT ANALYSIS 48

CHART 23 BOSTON SCIENTIFIC CORP.: OVERVIEW SNAPSHOT 51

CHART 24 BOSTON SCIENTIFIC CORP.: BUSINESS UNITS 52

CHART 25 BOSTON SCIENTIFIC CORP.: GEOGRAPHIC PRESENCE 53

CHART 26 BOSTON SCIENTIFIC CORP: SWOT ANALYSIS 54

CHART 27 B. BRAUN MELSUNGEN AG: OVERVIEW SNAPSHOT 56

CHART 28 B. BRAUN MELSUNGEN AG BUSINESS UNITS 57

CHART 29 B. BRAUN MELSUNGEN AG: GEOGRAPHIC PRESENCE 58

CHART 30 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS 59

CHART 31 MEDTRONIC PLC: OVERVIEW SNAPSHOT 67

CHART 32 MEDTRONIC PLC: BUSINESS UNITS 67

CHART 33 MEDTRONIC PLC: GEOGRAPHIC PRESENCE 68

CHART 34 MEDTRONIC PLC: SWOT ANALYSIS 70

CHART 35 MICROPORT SCIENTIFIC CORPORATION: OVERVIEW SNAPSHOT 73

CHART 36 MICROPORT SCIENTIFIC CORPORATION: BUSINESS UNITS 74

CHART 37 MICROPORT SCIENTIFIC CORPORATION: GEOGRAPHIC PRESENCE 75

CHART 38 MICROPORT SCIENTIFIC CORPORATION: SWOT ANALYSIS 76

 

 

 

 

Table of Contents

1 Industry Outlook 8

1.1 Industry Overview 8

1.2 Industry Trends 8

1.3 PEST Analysis 9

2 Report Outline 9

2.1 Report Scope 9

2.2 Report Summary 10

2.3 Research Methodology 11

2.4 Report Assumptions 11

3 Market Snapshot 12

3.1 Total Addressable Market 12

3.2 Segmented Addressable Market 12

3.3 Related Markets 13

3.3.1 Interventional Cardiology 13

3.3.2 Peripheral Vascular Stents 13

3.3.3 Atherectomy 14

4 Market Outlook 15

4.1 Market Definition-Infoholic Research 15

4.2 Causes for Coronary Heart Disease 15

4.3 Market Segmentation 15

4.4 Porter 5(Five) Forces 15

5 Market Characteristics 16

5.1 Evolution 16

5.2 Stents Platforms 17

5.3 Market Dynamics 18

5.3.1 Drivers 18

5.3.1.1 Increasing prevalence of cardiovascular diseases 18

5.3.1.2 Increasing aging population 18

5.3.1.3 Growing acceptance for minimally invasive endovascular surgeries 19

5.3.2 Opportunities 19

5.3.2.1 Market expansion opportunities in emerging nations 19

5.3.2.2 Increasing clinical trials 19

5.3.3 Restraints 19

5.3.3.1 Stringent regulations for approval 19

5.3.3.2 High cost of treatment associated with stent implants 20

5.3.3.3 Availability of alternative treatment procedure 20

5.4 DRO-Impact Analysis 20

5.5 Key Stakeholders 21

6 Coronary Stents Pipeline 22

6.1 Overview 22

7 Types: Market Size and Analysis 25

7.1 Overview 25

7.2 Bare Metal Stents (BMS) 25

7.3 Drug Eluting Stents 26

7.4 Bio-absorbable Stents 27

8 End-users: Market Size and Analysis 28

8.1 Overview 29

8.2 Hospitals 29

8.3 Ambulatory Surgical Centers (ASCs) 29

8.4 Cardiac Centers 30

9 Regions: Market Size and Analysis 30

9.1 Overview 30

9.2 North America 31

9.2.1 US 32

9.2.2 Canada 33

9.3 Europe 33

9.3.1 UK 34

9.3.2 Germany 34

9.3.3 France 35

9.4 Asia Pacific 35

9.4.1 Japan 36

9.4.2 China 36

9.4.3 India 36

9.5 Rest of the World 37

9.5.1 Africa 38

9.5.2 Brazil 38

10 Competitive Landscape 38

10.1 Overview 38

11 Vendors Profile 41

11.1 Abbott Laboratories (Abbott) 41

11.1.1 Overview 41

11.1.2 Business Unit 45

11.1.3 Geographic Presence 46

11.1.4 Business Focus 46

11.1.5 SWOT Analysis 47

11.1.6 Business Strategy 47

11.2 Boston Scientific Corp. (Boston) 48

11.2.1 Overview 48

11.2.2 Business Units 51

11.2.3 Geographic Presence 52

11.2.4 Business Focus 52

11.2.5 SWOT Analysis 53

11.2.6 Business Strategies 53

11.3 B. Braun Melsungen AG 54

11.3.1 Overview 54

11.3.2 Business Units 56

11.3.3 Geographic Presence 57

11.3.4 Business Focus 57

11.3.5 SWOT Analysis 58

11.3.6 Business Strategies 58

11.4 Medtronic Plc 59

11.4.1 Overview 59

11.4.2 Business Units 66

11.4.3 Geographic Presence 67

11.4.4 Business Focus 68

11.4.5 SWOT Analysis 69

11.4.6 Business Strategies 69

11.5 MicroPort Scientific Corporation 70

11.5.1 Overview 70

11.5.2 Business Units 73

11.5.3 Geographic Presence 74

11.5.4 Business Focus 75

11.5.5 SWOT Analysis 75

11.5.6 Business Strategies 76

12 Companies to Watch For 76

12.1 Terumo Corp. 77

12.1.1 Overview 77

12.2 Biosensors International Group 79

12.2.1 Overview 79

12.3 BIOTRONIK 80

12.3.1 Overview 80

12.4 Meril Life Science 81

12.4.1 Overview 81

12.5 STENTYS S.A. 82

12.5.1 Overview 82

12.5.2 Overview 82

Annexure 84

Abbreviations 84

 

Abbott Laboratories, Boston Scientific Corporation, Medtronic PLC, B. Braun Melsungen AG, Terumo Corporation, Biotronik SE & Co. KG, Stentys SA, MicroPort Scientific Corporation, and Meril Life Science, and other predominant


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person